Revvity | PKI - Kapitał Własny I Rezerwy

Cena Akcji
90.40
Dzienna Zmiana
2.61 2.97%
Miesięcznie
-1.86%
Rocznie
-10.80%
Q2 Prognozy TE
86.26




Kapitał Własny I Rezerwy Zmiana Data
Agilent USD 6.91B 167M 2025-12
Align Technology USD 3.96B 44.68M 2025-09
Bio Techne USD 2.01B 45.18M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Bruker USD 2.49B 625.6M 2025-09
Celltrion KRW 16.7T 182.36B 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Danaher USD 52.53B 1.46B 2025-12
Dentsply International USD 1.34B 139M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Divis Laboratories Ltd INR 154.13B 4.44B 2025-09
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Hologic USD 5.25B 197.2M 2025-12
Illumina USD 2.72B 342M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Mesa Laboratories USD 186.69M 8.22M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Organigram Holdings CAD 369.46M 20.33M 2025-12
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Pharma Mar EUR 251.83M 54.32M 2025-12
Qiagen NV USD 3.78B 128.73M 2025-12
Quest Diagnostics USD 7.17B 88M 2025-12
Quidel USD 1.92B 115.9M 2025-12
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Sartorius EUR 2.67B 9.9M 2025-09
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Tilray USD 1.58B 39.08M 2025-09
Waters USD 2.56B 230.55M 2025-12
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09